Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFDM Group Regulatory News (FDM)

Share Price Information for FDM Group (FDM)

Share Price is delayed by 15 minutes
Get Live Data
100.20    -5.60 (-5.29%)
Bid:
101.40
Ask:
105.60
Spread: 4.20 (4.142%)
Market Cap: £109.56m
FDM Live PriceLast checked at - London Stock Exchange

Intraday FDM Group Share Chart

Trading Statement

28 Jan 2026 07:00

RNS Number : 6290Q
FDM Group (Holdings) plc
28 January 2026
Β 

28 January 2026

FDM GROUP (HOLDINGS) PLC ("FDM GROUP", "FDM" or "THE GROUP")

YEAR END TRADING UPDATE

FDM Group, a global professional services provider with a focus on Information Technology, today provides a trading update for the year to 31 December 2025, ahead of its full year results, which will be released on 18 March 2026.

Group Trading in the Period and Closing Balance Sheet

The Board anticipates that the Group's financial performance for the year to 31 December 2025 will be within the range of market expectations1.

2025 was, much like the preceding two years, a challenging trading year. The Board has continued its focus on aligning resource levels to match client demand, as far as practicable, tailored to the specifics of each geographical operating market. As highlighted in the Group's trading update in November 2025, this included a cautious increase in the volume of consultants in training in the UK, North America and Australia in response to a degree of pick up in activity levels in some of our key operating geographies in the latter part of the year; the Group delivered 828 training completions during 2025 (2024: 877 training completions).

Revenue for the year to 31 December 2025 is expected to beΒ Β£178 million, down 31% (30% on a constant currency basis) in comparison to the prior year (2024:Β Β£258 million).

The Group ended the year with 2,003 Consultants placed with clients (2024: 2,578). TheΒ UKΒ closed with 910 Consultants deployed (2024: 1,056);Β North AmericaΒ closed with 500 Consultants deployed (2024: 742); APAC closed with 469 Consultants deployed (2024: 524); and EMEA closed with 124 Consultants deployed (2023: 256).

The Group's balance sheet remains robust with closing cash balances ofΒ Β£35 millionΒ (2024:Β Β£41 million). The Group has no debt.

Outlook

Rod Flavell, Group CEO, commented:

"We have been encouraged that the uptick in activity levels which we saw in the last four months of 2025 shows signs of continuing into early 2026. Clearly, the economic and political backdrops remain uncertain and market conditions remain subdued, but there are signs that an appreciable number of our clients have appetite for investment, with some of them already initiating activity.

Your Board will continue to align resources with demand, be prudent with investment and mindful of continuing market uncertainties. We are focussed on enabling FDM's return to growth as soon as our markets allow."

1Company-compiled range of analysts' expectations for FY25 Adjusted Profit Before Tax is Β£13.5m to Β£14.4m.

For further information please contact:

FDM Group

Rod Flavell - Chief Executive Officer

Mike McLaren - Chief Financial Officer

Mark Heather - Group Governance Director & Company Secretary

Β 

Β 

Tel: +44 (0)20 3056 8240

Β 

Financial PR

Nick Oborne

Tel: +44 (0)7850 127526

Β 

Forward-Looking Statements

This trading update may contain statements which constitute 'forward-looking statements'. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. Because these statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements. Subject to any requirement under the Disclosure Guidance and Transparency Rules or other applicable legislation, regulation or rules, the Group does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Neither shareholders nor prospective shareholders should place undue reliance on forward-looking statements, which speak only as of the date of this Trading Update.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTBRMBTMTBTTLF
Date   Source Headline
8th Jun 20268:24 amRNSDisclosure of PSP Performance Condition Targets
3rd Jun 202611:01 amRNSAdmission to Trading
2nd Jun 20262:23 pmRNSDirector Shareholding & Block Listing Application
1st Jun 20267:00 amRNSTotal Voting Rights
21st May 20264:39 pmRNSResult of AGM
21st May 20267:00 amRNSAGM Statement
27th Apr 20263:51 pmRNSNotification of Transactions of Directors & PDMRs
21st Apr 20262:18 pmRNSDirector / PCA Shareholding
20th Apr 20267:00 amRNSDirector / PCA Shareholding
10th Apr 20264:34 pmRNS2026 Notice of Annual General Meeting
20th Mar 20265:18 pmRNSHolding(s) in Company
18th Mar 20267:00 amRNSPreliminary Results
2nd Mar 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTotal Voting Rights
28th Jan 20267:00 amRNSTrading Statement
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
1st Dec 20259:17 amRNSTotal Voting Rights
13th Nov 202512:35 pmRNSHolding(s) in Company
11th Nov 20257:00 amRNSTrading Statement
6th Nov 20254:05 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTotal Voting Rights
17th Oct 20251:03 pmRNSDirector/PDMR Shareholding
4th Sep 20254:31 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSHolding(s) in Company
8th Aug 202510:55 amRNSDirector/PDMR Shareholding
5th Aug 202510:03 amRNSHolding(s) in Company
1st Aug 20258:50 amRNSTotal Voting Rights
31st Jul 20255:27 pmRNSPDMR Shareholding
31st Jul 20253:45 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSHalf-year Report
15th Jul 20255:07 pmRNSHolding(s) in Company
7th Jul 20259:48 amRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirectorate Change
6th Jun 20257:00 amRNSDirector/PDMR Shareholding
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
23rd May 20255:07 pmRNSDirector/PCA Shareholding
20th May 20255:28 pmRNSResult of AGM
20th May 20257:00 amRNSAnnual General Meeting Statement
9th May 202511:10 amRNSDirector/PDMR Shareholding
8th May 20252:55 pmRNSDirector/PDMR Shareholding
1st May 20251:17 pmRNSDirector/PDMR Shareholding
23rd Apr 20259:51 amRNSDirector Shareholding
9th Apr 20254:32 pmRNSDirector/PDMR Shareholding
8th Apr 20255:42 pmRNSNotice of Annual General Meeting
1st Apr 20257:00 amRNSTotal Voting Rights
20th Mar 20254:31 pmRNSDirector / PCR Shareholding
19th Mar 20257:00 amRNSDirectorate Change
19th Mar 20257:00 amRNSPreliminary Announcement of Results FY2024
14th Mar 20254:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.